Open Access
Issue |
Med Sci (Paris)
Volume 38, Number 8-9, Août-Septembre 2022
|
|
---|---|---|
Page(s) | 631 - 634 | |
Section | Le Magazine | |
DOI | https://doi.org/10.1051/medsci/2022090 | |
Published online | 12 September 2022 |
- Dubois M, Ardin C, André F, et al. L’immunothérapie, une révolution en oncologie : revue de l’efficacité des inhibiteurs de points de contrôle immunitaire. Med Sci (Paris) 2019 ; 35 : 937–945. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Girard JP, Moussion C, Forster R. HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes. Nat Rev Immunol 2012 ; 12 : 762–773. [CrossRef] [PubMed] [Google Scholar]
- Moussion C, Girard JP. Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules. Nature 2011 ; 479 : 542–546. [CrossRef] [PubMed] [Google Scholar]
- Martinet L, Garrido I, Filleron T, et al. Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer. Cancer Res 2011 ; 71 : 5678–5687. [CrossRef] [PubMed] [Google Scholar]
- Martinet L, Le Guellec S, Filleron T, et al. High endothelial venules (HEVs) in human melanoma lesions: major gateways for tumor-infiltrating lymphocytes. OncoImmunology 2012 ; 1 : 829–839. [CrossRef] [PubMed] [Google Scholar]
- Asrir A, Tardiveau C, Coudert J, et al. Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy. Cancer Cell 2022 ; 40 : 1–17. [Google Scholar]
- Blanchard L, Girard JP. High endothelial venules (HEVs) in immunity, inflammation and cancer. Angiogenesis 2021 ; 24 : 719–53. [CrossRef] [PubMed] [Google Scholar]
- Veerman K, Tardiveau C, Martins F, et al. Single-cell analysis reveals heterogeneity of high endothelial venules and different regulation of genes controlling lymphocyte entry to lymph nodes. Cell Rep 2019 ; 26 : 3116–3131. [CrossRef] [PubMed] [Google Scholar]
- Ley K, Kansas GS. Selectins in T-cell recruitment to non-lymphoid tissues and sites of inflammation. Nat Rev Immunol 2004 ; 4 : 325–336. [CrossRef] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.